Peter Hammerl

2.6k total citations
38 papers, 851 citations indexed

About

Peter Hammerl is a scholar working on Immunology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Peter Hammerl has authored 38 papers receiving a total of 851 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 13 papers in Molecular Biology and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Peter Hammerl's work include Immunotherapy and Immune Responses (8 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers) and T-cell and B-cell Immunology (6 papers). Peter Hammerl is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers) and T-cell and B-cell Immunology (6 papers). Peter Hammerl collaborates with scholars based in Austria, Germany and United States. Peter Hammerl's co-authors include Josef Thalhamer, Friedrich Grimminger, Werner Seeger, Jürgen Lohmeyer, Ulrich A. Maus, Simone Rosseau, Tobias Kiesslich, Kristjan Plaetzer, Barbara Krammer and Hans‐Dieter Walmrath and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and PLoS ONE.

In The Last Decade

Peter Hammerl

37 papers receiving 836 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Hammerl Austria 17 346 308 197 86 85 38 851
Robert A. Musson United States 14 191 0.6× 254 0.8× 173 0.9× 68 0.8× 55 0.6× 17 745
Min Cao China 17 195 0.6× 243 0.8× 230 1.2× 95 1.1× 44 0.5× 63 891
Ceri E. Stewart United Kingdom 13 201 0.6× 114 0.4× 199 1.0× 176 2.0× 46 0.5× 19 660
N.V. Vorobjeva Russia 13 156 0.5× 719 2.3× 438 2.2× 140 1.6× 62 0.7× 34 1.1k
Patricia Maier United States 13 479 1.4× 236 0.8× 240 1.2× 49 0.6× 75 0.9× 18 1.1k
Cheryl Black United Kingdom 13 92 0.3× 188 0.6× 230 1.2× 181 2.1× 45 0.5× 22 786
Erika Héninger United States 17 165 0.5× 348 1.1× 227 1.2× 41 0.5× 35 0.4× 44 894
Maha Zohra Ladjemi France 15 303 0.9× 256 0.8× 262 1.3× 147 1.7× 35 0.4× 24 835
K. Chul Kim United States 17 278 0.8× 341 1.1× 631 3.2× 130 1.5× 45 0.5× 20 1.1k
Sonja Möller Germany 14 105 0.3× 915 3.0× 329 1.7× 139 1.6× 86 1.0× 16 1.2k

Countries citing papers authored by Peter Hammerl

Since Specialization
Citations

This map shows the geographic impact of Peter Hammerl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Hammerl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Hammerl more than expected).

Fields of papers citing papers by Peter Hammerl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Hammerl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Hammerl. The network helps show where Peter Hammerl may publish in the future.

Co-authorship network of co-authors of Peter Hammerl

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Hammerl. A scholar is included among the top collaborators of Peter Hammerl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Hammerl. Peter Hammerl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Neureiter, Daniel, Renate Bauer, Harald Schwarz, et al.. (2020). IL‐31 transgenic mice show reduced allergen‐induced lung inflammation. European Journal of Immunology. 51(1). 191–196. 9 indexed citations
2.
Ortner, Daniela, Nadja Zaborsky, Richard Weiss, et al.. (2020). Epidermal activation of Hedgehog signaling establishes an immunosuppressive microenvironment in basal cell carcinoma by modulating skin immunity. Molecular Oncology. 14(9). 1930–1946. 24 indexed citations
3.
Deressa, Tekalign, Michael Wallner, Martin Himly, et al.. (2014). Structural Integrity of the Antigen Is a Determinant for the Induction of T-Helper Type-1 Immunity in Mice by Gene Gun Vaccines against E.coli Beta-Galactosidase. PLoS ONE. 9(7). e102280–e102280. 8 indexed citations
4.
Nishiyama, Tomoaki, Hidetoshi Sakayama, Peter Hammerl, et al.. (2013). Molecular and biochemical analysis of the first ARA6 homologue, a RAB5 GTPase, from green algae. Journal of Experimental Botany. 64(18). 5553–5568. 26 indexed citations
5.
Hoeper, Marius M., Stefan Andreas, Andreas Bastian, et al.. (2011). Pulmonary hypertension due to chronic lung disease: Updated Recommendations of the Cologne Consensus Conference 2011. International Journal of Cardiology. 154. S45–S53. 57 indexed citations
6.
Hoeper, Marius M., Stefan Andreas, Andreas Bastian, et al.. (2010). Pulmonale Hypertonie bei chronischen Lungenerkrankungen. DMW - Deutsche Medizinische Wochenschrift. 135(S 03). S115–S124. 4 indexed citations
7.
Hoeper, Marius M., Stefan Andreas, Andreas Bastian, et al.. (2010). Pulmonale Hypertonie bei chronischen Lungenerkrankungen. Pneumologie. 65(4). 208–218. 5 indexed citations
8.
Wallner, Michael, Theresa Thalhamer, Barbara Bohle, et al.. (2007). Allergy multivaccines created by DNA shuffling of tree pollen allergens. Journal of Allergy and Clinical Immunology. 120(2). 374–380. 36 indexed citations
9.
Günther, Andreas, Philipp Markart, Peter Hammerl, et al.. (2007). Safety and tolerability of bosentan in idiopathic pulmonary fibrosis: an open label study. European Respiratory Journal. 29(4). 713–719. 54 indexed citations
10.
Scheiblhofer, Sandra, Christina Guttmann‐Gruber, Cornelia Hauser‐Kronberger, et al.. (2006). Gene gun immunization with clinically relevant allergens aggravates allergen induced pathology and is contraindicated for allergen immunotherapy. Molecular Immunology. 44(8). 1879–1887. 14 indexed citations
11.
Weiss, Richard, Peter Hammerl, Arnulf Hartl, et al.. (2005). Design of Protective and Therapeutic DNA Vaccines for the Treatment of Allergic Diseases. Current Drug Targets - Inflammation & Allergy. 4(5). 585–597. 20 indexed citations
12.
13.
Hochreiter, Romana, et al.. (2002). Quantification of histamine in blood plasma and cell culture supernatants: a validated one-step gas chromatography–mass spectrometry method. Analytical Biochemistry. 308(2). 300–306. 24 indexed citations
14.
Leitner, Wolfgang W., Peter Hammerl, & Josef Thalhamer. (2001). Nucleic Acid for the Treatment of Cancer: Genetic Vaccines and DNA Adjuvants. Current Pharmaceutical Design. 7(16). 1641–67. 27 indexed citations
15.
Rosseau, Simone, Peter Hammerl, Ulrich A. Maus, et al.. (1999). Surfactant Protein A Down-Regulates Proinflammatory Cytokine Production Evoked by Candida albicans in Human Alveolar Macrophages and Monocytes. The Journal of Immunology. 163(8). 4495–4502. 70 indexed citations
16.
Hammerl, Peter, et al.. (1996). A non-expressed transgene as a cell marker for the investigation of cellular traffic after splenic autotransplantation. Journal of Immunological Methods. 194(2). 131–139. 4 indexed citations
17.
Hammerl, Peter, Arnulf Hartl, & Josef Thalhamer. (1993). Improvement of antisera raised against complex antigen mixtures by the use of heterologous sources of antigen for immunization. Journal of Immunological Methods. 160(2). 155–161. 3 indexed citations
18.
Hammerl, Peter, Arnulf Hartl, & Josef Thalhamer. (1993). Particulate nitrocellulose as a solid phase for protein immobilization in immuno-affinity chromatography. Journal of Immunological Methods. 165(1). 59–66. 11 indexed citations
19.
Hammerl, Peter, et al.. (1992). A method for the detection of serologically crossreacting antigens both within and between protein mixtures: the western cross blot. Journal of Immunological Methods. 151(1-2). 299–306. 2 indexed citations
20.
Hammerl, Peter, et al.. (1988). Antigenic competition in the immune response against protein mixtures: Strain-specific non-immunogenicity of Escherichia coli antigens. Molecular Immunology. 25(3). 313–320. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert A. Musson Breakdown of academic impact, for papers by Min Cao Breakdown of academic impact, for papers by Ceri E. Stewart Breakdown of academic impact, for papers by N.V. Vorobjeva Breakdown of academic impact, for papers by Patricia Maier Breakdown of academic impact, for papers by Cheryl Black Breakdown of academic impact, for papers by Erika Héninger Breakdown of academic impact, for papers by Maha Zohra Ladjemi Breakdown of academic impact, for papers by K. Chul Kim Breakdown of academic impact, for papers by Sonja Möller
Rankless by CCL
2026